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Submitted Nov 5, 2013; accepted Jan 24, 2014.DISCUSSIONDr Christian de Virgilio (Torrance, Calif). First off, I want
to thank the Western Vascular Surgery Society for the opportunity
to comment on this paper. I want to congratulate Dr Ham for
an excellent presentation. Dr Ham describes surgical repair
of 24 kidneys with complex renal artery pathology in 23 consec-
utive patients over a 25-year period. Using ex vivo cold preserva-
tion techniques, complex renal artery lesions were repaired and
reconstructed safely with low perioperative morbidity and no
mortality, and an impressive 5-year primary patency rate of
94%. There was only one late bypass graft occlusion, and 94%
of patients with pre-existing HTN were either cured or had sta-
tistically signiﬁcant improvement in BP and antihypertensive
medication requirements. A unique and important aspect of
this paper, as compared to other smaller series, is the long-term
follow-up, which was a mean of 44 months, as well as the careful
documentation of not only creatinine, but also creatinineclearance, kidney length, and cortical thickness. I would challenge
those who attempt these complex aneurysms via an endovascular
approach to provide similar meticulous follow-up. TheUSC group
should be commended for excellent outcomes. I had several
questions:
1) You mentioned in the manuscript that you utilized routine intra-
operative completion duplex scan to assess the adequacy of the
repair. What criteria did you use? And, what was your approach
when you detected a signiﬁcant lesion intraoperatively?
2) Though it was only one case, would you use cephalic vein
again?
3) Recently, there have been a few cases series utilizing laparo-
scopic nephrectomy with ex vivo repair and pelvic reimplanta-
tion for RAAA. Can you comment on the laparoscopic
approach?
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tient selection and operative technique evolved over that time,
and if so, how?
5) It is unclear from the manuscript how many of the renal artery
aneurysms were asymptomatic, and what size they were. What
size criterion do you utilize to operate on an asymptomatic
RAA? And, will that size cutoff change 15 minutes from now?
Dr Sung Wan Ham. Thank you, Dr de Virgilio, for your
comments and kind words. To address your ﬁrst question
regarding the use of intraoperative duplex to assess the adequacy
of repair, we look for velocity shifts and color-ﬂow disturbances
across the arterial anastomosis as well as inspecting ﬂow in the renal
vein. A decision to revise one or more anastomoses is dependent
on all these factors. In general, anastomoses with velocity shifts
of 3:1 or greater that are associated with a B mode defect and co-
lor-ﬂow disturbance would be candidates for revision. The decision
to reinstitute cold perfusion is made if revision is anticipated to
exceed 30 minutes.
Regarding your second question, our experience with cephalic
vein as renal artery conduit reminds us why the cardiac surgeons
stopped using them for coronary artery bypasses. The profound
intimal hyperplastic reaction we observed in a relatively short
period of time was likely due to the high-ﬂow rates that are seen
in the aortorenal position. Therefore, in the future, we will likely
use prosthetic over cephalic vein for aortorenal bypasses in patients
with no suitable saphenous vein.
As to your third question, there have been a few case reports
and small series successfully utilizing laparoscopic nephrectomy
modeled after live-donor transplant techniques with back bench
ex vivo reconstruction and heterotopic reimplantation in to the
pelvis. Claimed advantages of this technique include smaller inci-
sional morbidity and optimal surgical visualization at the back table
allowing meticulous dissection and complex reconstruction of
branch vessels. Other theoretic advantages include quicker recov-
ery and technically easier access for duplex surveillance. However,
compared to replacement of the kidney back into the renal fossa,the advantages of laparoscopic nephrectomy and pelvic autotrans-
plantation must be traded for an additional anastomosis between
the ureter and bladder and its associated complications of leak or
stricture formation. Furthermore, although there is nothing inher-
ently wrong with using the iliac vessels as arterial inﬂow, given the
relatively young age of the patients in our cohort, who had a mean
age of 45 years old, theoretical progression of atherosclerotic
occlusive disease of the iliac vessels over the remainder of their life-
time may compromise the renal reconstruction. Since the major
advantage of ex vivo reconstruction is the extended cold ischemia
time, which allows for precise branch vessel reconstruction, we
preferentially replace the kidney in its orthotopic position with
use of standard aortic attachment sites.
Regarding the question about our patient selection and oper-
ative techniques over time, our patient selection has been rather
constant over the years. Although more sophisticated catheter-
based techniques are now available to address these lesions, we
feel that open repair provides the best chance for renal preservation
in the long term. That is why we have not extended the indication
for repair to endovascular techniques in this highly select group of
patients. Over the past 25 years, there have been no major modi-
ﬁcations to our operative techniques. Our preference for replace-
ment of the reconstructed kidney to its original position in the
renal fossa over autotransplantation in to the pelvis was adopted
early on in our experience and has not changed over time.
As to you your last question, of the 24 renal arteries treated,
19 (79%) were aneurysmal. Of the 19 renal artery aneurysms,
eight (42%) of them were asymptomatic. The average size of
asymptomatic renal artery aneurysms was 1.9 cm and 2.9 cm
for symptomatic aneurysms. All patients who had asymptomatic
aneurysms were also hypertensive. Generally speaking, our indica-
tions for renal artery aneurysm repair are tailored to individual pa-
tient presentation, with surgical repair reserved for asymptomatic
aneurysms >2 cm in size and those in women of child bearing
age. That said, all patients in our series with asymptomatic aneu-
rysms had a mean aneurysm size of only 1.9 cm but had another
indication for surgery.
